Overview
Youxin Chen practices in Beijing, China. Chen is highly rated in 8 conditions, according to our data. Their top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Detachment, Vitrectomy, and Cataract Removal.
Their clinical research consists of co-authoring 311 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Age-Related Macular Degeneration (ARMD)
- Diabetic RetinopathyChen isDistinguished. Learn about Diabetic Retinopathy.
- Late-Onset Retinal DegenerationChen isDistinguished. Learn about Late-Onset Retinal Degeneration.
- Retinal DetachmentChen isDistinguished. Learn about Retinal Detachment.
- VitrectomyChen isDistinguished. Learn about Vitrectomy.
- Advanced
- Central Serous Chorioretinopathy
- NearsightednessChen isAdvanced. Learn about Nearsightedness.
- Retinal Vein Occlusion
- Experienced
- Acanthosis NigricansChen isExperienced. Learn about Acanthosis Nigricans.
- AchondroplasiaChen isExperienced. Learn about Achondroplasia.
- Acute Interstitial Pneumonia
- Adult-Onset Vitelliform Macular Dystrophy (AVMD)
- Allergic RhinitisChen isExperienced. Learn about Allergic Rhinitis.
- Bone TumorChen isExperienced. Learn about Bone Tumor.